The US Supreme Court Thursday unanimously upheld access to abortion pill Mifepristone, rejecting arguments against the FDA making it easily available.
The US Supreme Court (SCOTUS) Thursday unanimously preserved access to the abortion pill Mifepristone.
This might be a ruling to celebrate, but the elation unfortunately could be temporary. While it ruled the plaintiffs had no standing, the conservative wing of SCOTUS left the door open to a future challenge to the FDA's rules regarding mifepristone. This case had so many holes in it, it should've been dismissed, and future challenges should be given that treatment as well.
It's disappointing that SCOTUS hasn't held the FDA accountable. Mifepristone brings numerous harms to women and doctors, who have been abandoned by pro-abortion factions and their media protectors. But this is just the first ruling, and future challenges to the drug's availability will hopefully lead to tighter restrictions and a safer environment for pregnant women.